ANTICENTROMERE ANTIBODY - ANVISA Registration 80254180123

Access comprehensive regulatory information for ANTICENTROMERE ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180123 and manufactured by PHADIA AB. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
2 Competitors
80254180123
Registration Details
ANVISA Registration Number: 80254180123
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80254180123

25351227472201077

04930429000139

Company Information

PHADIA AB
Sweden
PT: SUÉCIA

Dates and Status

Jun 23, 2010

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "ANTICENTROMERE ANTIBODY"